Sort by
Refine Your Search
-
will conduct original and collaborative research; author and co-author peer-reviewed publications; collaborate in ongoing projects and develop new research proposals; and help supervise and train
-
18 Apr 2024 Job Information Organisation/Company THE UNIVERSITY OF HONG KONG Research Field Computer science Educational sciences Researcher Profile Recognised Researcher (R2) First Stage Researcher
-
communication abilities, and a collaborative attitude. The appointee will conduct original and collaborative research; author and co-author peer-reviewed publications; collaborate in ongoing projects and develop new
-
problem-solving skills the ability to multi-task and work on a tight schedule to meet project deadlines the ability to work well independently and collaboratively as a team the capacity to develop and
-
& cell therapy, immunotherapy, nucleic acids therapeutics for brain cancer and neurodegenerative diseases. Duties and Responsibilities: Design and develop small molecules, nucleic acids and peptide
-
programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Work type: Full-time Department: Faculty of Education (10000) Categories: Senior Research Staff & Post
-
of renewal subject to satisfactory performance and funding availability) Applicants should have a Ph.D. in Developmental/Educational Psychology or other related discipline. They should have good academic
-
develop and implement a tiered intervention model: supporting the learning of English as a second language for primary school students with reading and writing difficulties. He/Shewill design and carry out
-
Examinations and Assessment Authority outside CUHK. The RAP will be responsible for working on the application of large language models in language learning/teaching, assessment, and therapy. Candidates should
-
well as the Centre for Comparative Medicine Research (CCMR) of the University of Hong Kong. Our goal is to develop novel therapeutic agents and personalized strategies for AML and other blood cancer types with a focus